Blume Capital Management, Inc. Quest Diagnostics Inc Transaction History
Blume Capital Management, Inc.
- $481 Million
- Q2 2025
A detailed history of Blume Capital Management, Inc. transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Blume Capital Management, Inc. holds 45 shares of DGX stock, worth $6,169. This represents 0.0% of its overall portfolio holdings.
Number of Shares
45
Previous 2
2150.0%
Holding current value
$6,169
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding DGX
# of Institutions
1,087Shares Held
102MCall Options Held
468KPut Options Held
722K-
Vanguard Group Inc Valley Forge, PA13.9MShares$1.91 Billion0.04% of portfolio
-
Black Rock Inc. New York, NY10.1MShares$1.38 Billion0.03% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.98MShares$820 Million0.12% of portfolio
-
State Street Corp Boston, MA5.18MShares$710 Million0.03% of portfolio
-
Jpmorgan Chase & CO New York, NY3.77MShares$517 Million0.04% of portfolio
About QUEST DIAGNOSTICS INC
- Ticker DGX
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 113,887,000
- Market Cap $15.6B
- Description
- Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...